Syncom Formulations (India) Limited, a active public limited company, was established on 21 June 1988 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24239MH1988PLC047759. Registered under ROC Roc Mumbai. it is listed on BSE: 524470. It has an authorized capital of ₹95.00 Cr and a paid-up capital of ₹94.00 Cr.
Formerly known as Syncom Formulations (India) Pvt Limited. It upholds a compliant status. In 2024, it reported revenue of ₹271.46 Cr and a net worth of ₹286.45 Cr. Employing 681 professional, Its leadership includes Ritesh Kumar Lunkad (Director), Ankit Jain (Director), Kedarmal Shankarlal Bankda (Whole-Time Director). Past directors included Praveen Jindal, Arpit Gupta, Ramesh Mishra. It holds ₹9.50 Cr open charges and ₹156.68 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 7, Niraj Industrial Estate, Off Mahakali Caves Road Andheri (East), Mumbai, Maharashtra, 400093.
L24239MH1988PLC047759
047759
21 June 1988
₹95.00 Cr
₹94.00 Cr
Roc Mumbai
Listed (BSE: 524470)
Active
Explore comprehensive insights into Syncom Formulations (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ritesh Kumar Lunkad | Director | 14 Aug 2023 | Current |
| Ankit Jain | Director | 14 Aug 2023 | Current |
| Kedarmal Shankarlal Bankda | Whole-Time Director | 13 Apr 1992 | Current |
| Vijay Shankarlal Bankda | Managing Director | 01 Dec 1999 | Current |
| Ruchi Jindal | Director | 28 Jun 2022 | Current |
| Ankit Kedarmal Bankda | Cfo | 01 Apr 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Sep 2012 | Past |
| Pramod Abcsdd | Director | 01 Oct 2008 | Past |
| Pramod Abcsdd | Director | 30 Apr 2007 | Past |
| Pramod Abcsdd | Director | 31 Mar 2024 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2023 | Past |
| Pramod Abcsdd | Director | 12 Jul 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Syncom Formulations (India) Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 13.46% increase. The company also saw a substantial improvement in profitability, with a 17.7% increase in profit. The company's net worth Soared by an impressive increase of 11.89%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Syncom Formulations (India) had a promoter holding of 50.57% and a public holding of 49.43%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹95,000,000.00
₹1,566,792,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Oct 2025 | Hdfc Bank Limited | ₹9.50 Cr | Open |
| 28 Dec 2020 | Hdfc Bank Limited | ₹100.00 Cr | Satisfied |
| 23 May 2002 | Dena Bank | ₹12.77 Cr | Satisfied |
| 23 May 2002 | Dena Bank | ₹12.77 Cr | Satisfied |
| 27 Mar 2000 | Dena Bank | ₹4.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Syncom Formulations (India) has a workforce of 681 employees as of Mar 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Syncom Formulations (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syncom Formulations (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 9.50 Cr with Charge ID 101172185 was registered on 01 Oct 2025. was documented.
The activity Rahul Vijay Bankda was appointed as a Cfo was appointed as a Cfo on 08 Sep 2025 & has been associated with this company since 4 months 6 days . was completed.
A charge registered on 28 Dec 2020 via Charge ID 100407475 with Hdfc Bank Limited was fully satisfied on 27 Mar 2025. was recorded as a recent event.
Progress on Syncom Formulations (India) Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Syncom Formulations (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Ritesh Kumar Lunkad was appointed as a Director was appointed as a Director on 14 Aug 2023 & has been associated with this company since 2 years 5 months . was recorded as a recent event.
Syncom Formulations India has informed about Outcome of Board Meeting held on February 13, 2017..
The CIN of Syncom Formulations (India) Limited is L24239MH1988PLC047759.
Syncom Formulations (India) Limited is headquartered at 7, Niraj Industrial Estate, Off Mahakali Caves Road Andheri (East), Mumbai, Maharashtra, 400093.
Syncom Formulations (India) Limited was incorporated on 21 June 1988.
The current directors of Syncom Formulations (India) Limited are
The primary industry of Syncom Formulations (India) Limited is Manufacturing.
Syncom Formulations (India) Limited is listed. It is listed on BSE: 524470.
The authorized capital of Syncom Formulations (India) Limited is ₹95.00 Cr, and the paid-up capital is ₹94.00 Cr.
The compliance status of Syncom Formulations (India) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX